HedgeMountain

MPM BioImpact Innovations Equities Master, LP

Boston, MA · CIK 2028760

MPM BioImpact Innovations Equities Master, LP is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed Jun 26, 2026, the fund has sold $105,210,597 of interests to 10 investors since its first sale in Jun 2024. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Christiana Bardon; MPM BioImpact Innovations Equities GP, LLC; Kristen Laguerre.

Performance

No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to HedgeMountain directly.

Is this your fund? Report your monthly returns · How performance works

Total raised
$105,210,597Cumulative sales reported on Form D
Investors
10
First sale
Jun 3, 2024
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Christiana Bardon; MPM BioImpact Innovations Equities GP, LLC; Kristen Laguerre
Latest Form D
Jun 26, 2026

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures

Size compared with every hedge fund

Raised more than 49% of the 472 hedge funds based in Massachusetts, and more than 58% of all 10,157 that report sales.

Other funds with the same team

More hedge funds in Boston